Clinical Hypertension is the official journal of the Korean Society of Hypertension.
The Society is currently covering all publication costs so there are no article processing charges for authors.
Page 1 of 4
Arterial stiffness is associated with myocardial ischemia and incident coronary artery disease (CAD), and indexes of arterial stiffness are usually increased in patients with CAD. However, these indexes are of...
Citation: Clinical Hypertension 2021 27:5
An amendment to this paper has been published and can be accessed via the original article.
Citation: Clinical Hypertension 2021 27:10
BENEFIT-KOREA (BEnefits after 24 weeks of NEbivolol administration For essential hypertensIon patients wiTh various comorbidities and treatment environments in Korea) study, an observational study in South Kor...
Citation: Clinical Hypertension 2021 27:9
The Korean Society of Hypertension has published the Korea Hypertension Fact Sheet 2020 to provide an overview of the magnitude and management status of hypertension and their recent trends.
Citation: Clinical Hypertension 2021 27:8
It is known in some studies that higher the LDL-C, the greater the risk of developing cardiovascular disease. However, studies of the causal effects between LDL-C and hypertension are limited by their observat...
Citation: Clinical Hypertension 2021 27:7
Previous studies that investigated association of height with prevalence and control of hypertension found mixed results. This cross-sectional study explored these associations among US adults (≥20 years).
Citation: Clinical Hypertension 2021 27:6
Smartphone technology has spread rapidly around the globe. According to a report released by the Korea Information Society Development Institute, about 95% of Koreans aged more than 30 years old owned smartpho...
Citation: Clinical Hypertension 2021 27:4
Hypertension, the most common comorbidity among coronavirus disease 2019 (COVID-19) patients, is accompanied by worse clinical outcomes, but there is lack of evidence about prognostic factors among COVID-19 pa...
Citation: Clinical Hypertension 2021 27:3
High dietary salt and a lack of reduced blood pressure (BP) at night (non-dipping) are risk factors for the development of hypertension which may result in end-organ damage and death. The effect of high dietar...
Citation: Clinical Hypertension 2021 27:2
Hypertension is a major public health problem and a prominent risk factor for cardiovascular diseases. However, whether passive smoking exposure (PSE) is associated with the risk of hypertension is scarcely un...
Citation: Clinical Hypertension 2021 27:1
Although recent hypertension guidelines recommend home blood pressure (HBP) monitoring, its effect in clinical practice is not well known. This study aimed to identify current HBP measurement status and obstac...
Citation: Clinical Hypertension 2020 26:24
Globally hypertension in adults is among the leading preventable cause of premature death, where a graded association from the childhood hypertension is well recognised. With the concurrent rise in obesity and...
Citation: Clinical Hypertension 2020 26:22
Hypertension is a chronic health condition in which blood pressure is usually elevated beyond normal levels. It can progress with serious complications if left undetected and untreated. Incidence of hypertensi...
Citation: Clinical Hypertension 2020 26:23
According to the last Hypertension guideline recommendations, it may be concluded that intensive BP lowering is only advisable in a subgroup of patients where there is a clear net benefit of targeting to lower...
Citation: Clinical Hypertension 2020 26:21
The risk associated with serum uric acid (SUA) levels when within the normal range is unknown. This study aims to examine whether SUA within the normal range is a predictor of hypertension.
Citation: Clinical Hypertension 2020 26:20
This study was aimed at determining the levels of serum adiponectin, leptin, resistin, visfatin and lipids during the first trimester in pregnant women and to evaluate the relationship between these biochemica...
Citation: Clinical Hypertension 2020 26:19
Hypertension is a major risk factor for cardiovascular disease, which is the leading cause of mortality globally. Patient’s adherence to treatment is a cornerstone factor in controlling hypertension and its co...
Citation: Clinical Hypertension 2020 26:18
Pulmonary thromboembolism (PTE) is thought to usually stem from deep vein thrombosis (DVT). However, evidence of DVT could not be found in many cases. Furthermore, transient thyrotoxicosis is a rare but potent...
Citation: Clinical Hypertension 2020 26:17
Preeclampsia is a complex syndrome that is considered a disorder specific to pregnancy. However, research indicates that diffuse maternal endothelial damage may persist after childbirth. On the other hand, wom...
Citation: Clinical Hypertension 2020 26:16
Chronic kidney disease (CKD) is a significant comorbidity among hypertensive patients. Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) have been demonstrated to be significantly associated wit...
Citation: Clinical Hypertension 2020 26:15
There is current debate concerning the use of angiotensin-converting enzyme (ACE) inhibitors or angiotensin II type 1 receptor blockers (ARBs), for hypertension management, during COVID-19 infection. Specifica...
Citation: Clinical Hypertension 2020 26:14
Addressing chronic diseases is a challenge for healthcare systems worldwide, which have largely developed to deal with acute episodic care, rather than to provide organized care for people with age-long condit...
Citation: Clinical Hypertension 2020 26:12
Hyperuricemia, which has been considered as a cause of gout and nephrolithiasis has recently been suggested to be associated with hypertension, coronary heart disease, heart failure, atrial fibrillation, insul...
Citation: Clinical Hypertension 2020 26:13
Hypertension, itself being a major chronic condition, is one of the most significant risk factors for premature cardiovascular diseases and mortality. Hypertension is responsible for 13% of global deaths and t...
Citation: Clinical Hypertension 2020 26:10
The incidence of hypertension is increasing worldwide and obesity is one of the most significant risk factors. Obesity can be defined by various anthropometric indices such as body mass index (BMI), waist-to-h...
Citation: Clinical Hypertension 2020 26:9
Antihypertensive drugs are one of the most widely used pharmacologic agent in the world and it is predominantly used in the elderly subjects. Pneumonia is the most common cause of death in the extremely old su...
Citation: Clinical Hypertension 2020 26:11
Blood pressure (BP) are uncontrolled in over 80% hypertensive population in China, indicating a compelling need for a pragmatic hypertension management strategy. The 2018 Chinese hypertension guidelines issued...
Citation: Clinical Hypertension 2020 26:8
Zonulin has been implicated in many metabolic disorders including hypertension and obesity. However, there is insufficient information about the involvement of zonulin in pregnancy induced hypertension (PIH) w...
Citation: Clinical Hypertension 2020 26:7
Renal artery stenosis is a notorious cause of secondary hypertension which classically presents as chronic refractory hypertension, recurrent flash pulmonary edema or renal insufficiency after initiation of an...
Citation: Clinical Hypertension 2020 26:6
Although dietary modification is strongly recommended for prevention and treatment of hypertension, little is known about which factors are associated with adherence to dietary guidelines. We investigated know...
Citation: Clinical Hypertension 2020 26:5
To analyze the association between hypertension and urinary uric acid excretion in patients with chronic kidney disease (CKD).
Citation: Clinical Hypertension 2020 26:4
The Korean Society of Hypertension (KSH) revised the local guidelines for hypertension in 2018. The present study sought to evaluate the potential impact of the 2018 KSH guidelines on hypertension management s...
Citation: Clinical Hypertension 2020 26:3
Systolic blood pressure (SBP) and diastolic blood pressure (DBP) tends to increase with age and increase in proportion to body weight and height. Recent epidemiological and longitudinal cohort studies have fou...
Citation: Clinical Hypertension 2020 26:2
Hypertension is a leading cause of cardiovascular disease, stroke, and death. It affects a substantial proportion of the population worldwide, and remains underdiagnosed and undertreated.
Citation: Clinical Hypertension 2020 26:1
Although there has been a well-established association between overweight-obesity and hypertension, whether such associations are heterogeneous for South Asian populations, or for different socioeconomic group...
Citation: Clinical Hypertension 2019 25:28
Hypertension control is a major public health concern. Daily preventive practices of the affected individual are essential for controlling blood pressure (BP). We investigated the association of diet managemen...
Citation: Clinical Hypertension 2019 25:24
Hypertension is one of the most relevant risk factors in vascular aging, stroke and vascular dementia (VD). In the elderly, the prevalence of mixed dementia, which consists of Alzheimer’s disease (AD) and VD, ...
Citation: Clinical Hypertension 2019 25:27
The significance of high systolic and diastolic blood pressure remains controversial. We assessed the differences in prevalence of hypertension and its subtypes according to the different hypertension diagnost...
Citation: Clinical Hypertension 2019 25:26
We have read with interest the Korean Society of Hypertension guidelines for the management of hypertension and congratulate the Society for an extensive review of literature while drafting the guidelines. The...
Citation: Clinical Hypertension 2019 25:25
17α-hydroxylase deficiency is a rare autosomal recessive disorder caused by mutations in the cytochrome P450 family 17 subfamily A member 1 gene. The major clinical presentation includes hypertension, hypokale...
Citation: Clinical Hypertension 2019 25:23
Pulmonary arterial hypertension (PAH) is known as one of diseases with the worst prognosis. Recently, targeted PAH drugs have been developed and approved for use; therefore, the treatment strategy and goals ha...
Citation: Clinical Hypertension 2019 25:22
Pulmonary arterial hypertension (PAH) is a progressive, chronic disease without curative treatment. Large registry data of these patient populations have been published, although, phenotypic variants within ea...
Citation: Clinical Hypertension 2019 25:21
This study was performed to compare the associations of brachial-ankle pulse wave velocity (baPWV) and central blood pressure (CBP) measurements with left ventricular (LV) geometry and diastolic function.
Citation: Clinical Hypertension 2019 25:18
To explore the familial aggregation and heritability of hypertension in Han in Shanghai China.
Citation: Clinical Hypertension 2019 25:17
The standardized techniques of blood pressure (BP) measurement in the clinic are emphasized and it is recommended to replace the mercury sphygmomanometer by a non-mercury sphygmomanometer. Out-of-office BP mea...
Citation: Clinical Hypertension 2019 25:20
Treatment of hypertension improves cardiovascular, renal, and cerebrovascular outcomes. However, the benefit of treatment may be different according to the patients’ characteristics. Additionally, the target b...
Citation: Clinical Hypertension 2019 25:19
The Korean Society of Hypertension guideline defines hypertension as systolic blood pressure ≥ 140 mmHg or diastolic blood pressure ≥ 90 mmHg, where the effectiveness of pharmacological treatment has been esta...
Citation: Clinical Hypertension 2019 25:16
Preeclampsia is a serious pregnancy-related disease which may lead to adverse health effects to the mother and fetus. Besides many publications on the association of red cell distribution width (RDW) and preec...
Citation: Clinical Hypertension 2019 25:15
Preeclampsia is leading causes of maternal and perinatal morbidity and mortality worldwide and it is a hypertensive disorder which usually occurs after 20 weeks of gestation. In Ethiopia, according to Ethiopia...
Citation: Clinical Hypertension 2019 25:14
The dysregulation of histone deacetylase (HDAC) protein expression or its enzyme activity is implicated in a variety of diseases. Cardiac HDAC6 and HDAC8 enzyme activity induced by deoxycorticosterone acetate ...
Citation: Clinical Hypertension 2019 25:13
Clinical Hypertension is the official journal of the Korean Society of Hypertension.
The Society is currently covering all publication costs so there are no article processing charges for authors.
Speed
58 days to first decision for reviewed manuscripts only
44 days to first decision for all manuscripts
117 days from submission to acceptance
45 days from acceptance to publication
Usage
127,397 Downloads
114 Altmetric Mentions